NCT06981546

Brief Summary

Gambling disorder (GD) is recognized as an addictive disorder. Financial consequences of GD are often dramatic, inducing professional, familial, legal and medical repercussions and particularly mental health consequences. MOGADOR is a longitudinal, multicentric, prospective, prognostic study, which aims to identify factors predicting the evolution of french patients with GD in care centers particularly involved in the management of GD. The main goal will focus on evolution of DSM-5 (Diagnostic and Statistical Manual of Mental Disorder 5th edition) GD criteria during the first year of follow-up. The prognostic factors will be collected at base-line and they will be considered to influence the long-term prognosis of patients. For patients suffering of GD, our main hypothesis is that initial factors like individual socio-demographic characteristics, clinical psychiatric profiles, addiction comorbidities, and behaviour are associated with the clinical prognosis (total remission of DSM-5 criteria of GD at 12 months). MOGADOR will be the first study, aiming to model prognostic aspects of GB in populations specially monitored for this disorder.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
268

participants targeted

Target at P75+ for all trials

Timeline
53mo left

Started Sep 2025

Longer than P75 for all trials

Geographic Reach
1 country

9 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Sep 2025Sep 2030

First Submitted

Initial submission to the registry

May 5, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 20, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2030

Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

4 years

First QC Date

May 5, 2025

Last Update Submit

May 13, 2025

Conditions

Keywords

Gambling disordersModeling outcomesSocio-demographic CharacteristicsClinical psychiatric profiles

Outcome Measures

Primary Outcomes (2)

  • Partial remission of gambling disorder at 12 months (strictly less than 4 DSM-5 criteria)

    Assessment of DSM-5 criteria will be performed by the clinician, and by a previously trained CRA if clinical follow-up is discontinued.

    DSM-5 criteria assessment will be conducted at 9 and 12 months after inclusion.

  • modeling prognostic factors

    The prognostic factors, studied will be: number of initial DSM-5 criteria, gender, age, marital status, housing, employment status, socioeconomic level, time spent gambling, impulsivity, type of gambling, location of gambling, and also the factor with the strongest association in univariate analysis among the following factors: * Depression (PHQ scale), * Anxiety (GAD scale), * Quality of life (SF-36 scale).

    at inclusion visit.

Study Arms (1)

Patients with gambling disorder

OGADOR will focus exclusively on patients with DSM-5 criteria for gambling disorder and on demand for medical care. In this study psychiatric and addictological comorbidities, frequent in such a cohort, will constitute a specific inclusion factor, key characteristic leading an analysis of the impact on the patient prognosis.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

268 patients with gambling disorder according to DSM-5 criteria newly managed in one of the participating centers or who had an interruption in management of more than 6 months.

You may qualify if:

  • Patient, male or female, over 18 years old, consulting in one of the participating centers.
  • First treatment for gambling disorder or no treatment in the last 6 months (initiation or re-initiation of care).

You may not qualify if:

  • Unable to be reached by phone.
  • Unable to use the internet.
  • Patient under antiparkinsonian treatment of the dopaminergic family.
  • Being treated with a drug that may trigger/increase symptoms of gambling disorder (e.g. dopamine agonist).
  • Subject under guardianship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Hôpital Jen Minjoz, CHU de Besançon

Besançon, 25030, France

Location

Service Universitaire d'Addictologie de Lyon (SUAL), CH Le Vinatier

Bron, 69500, France

Location

Service Universitaire d'Addictologie de Lyon (SUAL), Groupement Hospitalier Est

Bron, 69500, France

Location

Service Universitaire d'Addictologie, CHU de Clermont-Ferrand

Clermont-Ferrand, 63000, France

Location

Name of location * Service d'Addictologie, Groupe Hospitalier Seclin Carvin

Lille, 59000, France

Location

Centre Expert Régional du Jeu Pathologique (CERJeP Limousin)

Limoges, 87000, France

Location

Service Universitaire d'Addictologie, CHU de Nîmes

Nîmes, 30000, France

Location

Assistance Publique des Hôpitaux de Paris, Hôpital Marmottan

Paris, 75017, France

Location

Hôpital de Bellevue, CHU de St-Etienne

Saint-Etienne, 42000, France

Location

MeSH Terms

Conditions

Gambling

Condition Hierarchy (Ancestors)

Risk-TakingBehaviorDisruptive, Impulse Control, and Conduct DisordersMental Disorders

Central Study Contacts

Véronique FONTEILLE, MD, PhD

CONTACT

Pauline DROUIN

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2025

First Posted

May 20, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

September 1, 2029

Study Completion (Estimated)

September 1, 2030

Last Updated

May 20, 2025

Record last verified: 2025-05

Locations